Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Jenkins

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Molecular Cancer Therapeutics|December 28, 2023
The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase InhibitorsRobert W Robey, Christina M Fitzsimmons, Wilfried M Guiblet, et al.
Nature Communications|February 24, 2024
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcomaYong Yean Kim, Berkley E Gryder, Ranuka Sinniah, et al.
Cell|April 6, 2019
exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present across Human BiofluidsOscar D Murillo, William Thistlethwaite, Joel Rozowsky, et al.
Cancer Discovery|July 30, 2025
Expression of IMPACT curtails metabolic plasticity and augments NK cell killing to abrogate metastatic growthSurajit Sinha, Abir Kumar Panda, Rodrigo Xavier das Neves, et al.
Cancer Discovery|September 30, 2025
Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic GrowthSurajit Sinha, Abir Kumar Panda, Rodrigo Xavier das Neves, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Molecular Cancer Therapeutics|December 28, 2023
The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase InhibitorsRobert W Robey, Christina M Fitzsimmons, Wilfried M Guiblet, et al.
Nature Communications|February 24, 2024
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcomaYong Yean Kim, Berkley E Gryder, Ranuka Sinniah, et al.
Cell|April 6, 2019
exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present across Human BiofluidsOscar D Murillo, William Thistlethwaite, Joel Rozowsky, et al.
Cancer Discovery|July 30, 2025
Expression of IMPACT curtails metabolic plasticity and augments NK cell killing to abrogate metastatic growthSurajit Sinha, Abir Kumar Panda, Rodrigo Xavier das Neves, et al.
Cancer Discovery|September 30, 2025
Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic GrowthSurajit Sinha, Abir Kumar Panda, Rodrigo Xavier das Neves, et al.
Pageof 8